Novo Director: If someone is going to do it, it’s us
According to the Director of Global Research at Novo Nordisk, Peter Kurtzhals, the company has come closer to the realization of what he called the ultimate step in diabetes treatment just a few years ago. The director also explains which research projects in the pipeline are most exciting to him.
BY STEFAN SINGH KAILAY
Three years ago it was the ultimate step and now Novo Nordisk is already reading through data from the phase 2a study. This is the statement from the company’s Director for Global Research, Peter Kurtzhals, in relation to the development of insulin in pill form.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo’s prize asset shows potential in Alzheimer’s
For abonnenter
